Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Morbilinum is a homeopathic nosode prepared from the secretions of individuals infected with the measles virus (Measles morbillivirus). In homeopathic medicine, it is utilized based on the principle of "Similia Similibus Curentur" (like cures like) to treat symptoms that resemble measles, such as high fever, skin eruptions, and respiratory catarrh. It is also used in homeopathic protocols for "homeoprophylaxis" or to address long-term effects attributed to the measles virus. As a homeopathic product, it undergoes serial dilution and succussion, typically to potencies (e.g., 30C, 200C) where no original viral material remains. It is regulated as a homeopathic drug in various jurisdictions but is not recognized by conventional medical authorities as a substitute for the Measles, Mumps, and Rubella (MMR) vaccine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on morbilinum.